Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis.
Background: Ursodeoxycholic acid (UDCA) is the only approved treatment for primary biliary cirrhosis, but its effect on disease progression and survival is uncertain. The aim of this study was to clarify the efficacy of UDCA in primary biliary cirrhosis.Methods: A systematic review, including the us...
| Published in: | Lancet Vol. 354; no. 9184; pp. 1053 - 1061 |
|---|---|
| Main Authors: | , , , , , |
| Format: | research systematic review tables/charts Journal Article |
| Published: |
Lancet
9/25/1999
|
| Online Access: | View this record in EBSCOhost |